The Journal of Immunology, Vol 148, Issue 11 3572-3577, Copyright © 1992 by American Association of Immunologists

ARTICLES

Vasoactive intestinal peptide stimulates T lymphocytes to release IL-5 in murine schistosomiasis mansoni infection

RC Mathew, GA Cook, AM Blum, A Metwali, R Felman and JV Weinstock
Department of Internal Medicine, University of Iowa College of Medicine, Iowa City 52242.

In murine schistosomiasis, granulomas form around ova deposited in the liver and intestines of infected mice. The granulomas have eosinophils that produce vasoactive intestinal peptide (VIP) and T cells that display VIP receptors. IL-5 is a lymphokine important for the development and maturation of eosinophils. It seemed plausible that VIP, released from eosinophils, may interact with lymphocyte VIP receptors and modulate IL-5 production as part of a feedback regulatory circuit. Thus, we determined whether granuloma T cells make IL-5 and whether VIP modulates IL-5 production. Isolated granuloma cells enriched for T lymphocytes spontaneously released IL-5. Culture of these cells in the presence of VIP increased IL-5 secretion. Spleen cells were also studied. Spleen cells from infected mice did not spontaneously release IL-5 or express IL-5 mRNA and VIP did not stimulate these resting spleen cells to produce this IL. However, these cells did express IL-5 mRNA and secreted IL-5 in response to Con A or soluble egg Ag. VIP could not appreciably modulate IL-5 release when cells were cultured with VIP and the Ag or mitogen. Spleen cells washed free of Con A ceased IL-5 secretion within 24 h. These preactivated splenic T cells resumed vigorous IL-5 secretion in response to either Con A or VIP. Yet only Con A prominently induced IL-5 mRNA expression. VIP was an effective stimulus at concentrations equal to or above the kDa of the VIP receptor on both splenic and granuloma T cells (10(-8) M). It is concluded that, in murine schistosomiasis, VIP invokes IL-5 release from activated T cells that are not undergoing immediate TCR stimulation.

This article has been cited by other articles:

				M.-C. Huang, A. L. Miller, W. Wang, Y. Kong, S. Paul, and E. J. Goetzl Differential Signaling of T Cell Generation of IL-4 by Wild-Type and Short-Deletion Variant of Type 2 G Protein-Coupled Receptor for Vasoactive Intestinal Peptide (VPAC2). J. Immunol., June 1, 2006; 176(11): 6640 - 6646. [Abstract] [Full Text] [PDF]

				M. Delgado, D. Pozo, and D. Ganea The Significance of Vasoactive Intestinal Peptide in Immunomodulation Pharmacol. Rev., June 1, 2004; 56(2): 249 - 290. [Abstract] [Full Text] [PDF]

				M. A. Summers, M. S. O'Dorisio, M. O. Cox, M. Lara-Marquez, and E. J. Goetzl A Lymphocyte-Generated Fragment of Vasoactive Intestinal Peptide with VPAC1 Agonist Activity and VPAC2 Antagonist Effects J. Pharmacol. Exp. Ther., August 1, 2003; 306(2): 638 - 645. [Abstract] [Full Text] [PDF]

				J. K. Voice, C. Grinninger, Y. Kong, Y. Bangale, S. Paul, and E. J. Goetzl Roles of Vasoactive Intestinal Peptide (VIP) in the Expression of Different Immune Phenotypes by Wild-Type Mice and T Cell-Targeted Type II VIP Receptor Transgenic Mice J. Immunol., January 1, 2003; 170(1): 308 - 314. [Abstract] [Full Text] [PDF]

				A. Metwali, A. M. Blum, D. E. Elliott, and J. V. Weinstock IL-4 inhibits vasoactive intestinal peptide production by macrophages Am J Physiol Gastrointest Liver Physiol, July 1, 2002; 283(1): G115 - G121. [Abstract] [Full Text] [PDF]

				J. K. VOICE, G. DORSAM, H. LEE, Y. KONG, and E. J. GOETZL Allergic diathesis in transgenic mice with constitutive T cell expression of inducible vasoactive intestinal peptide receptor FASEB J, November 1, 2001; 15(13): 2489 - 2496. [Abstract] [Full Text] [PDF]

				E. J. Goetzl, J. K. Voice, S. Shen, G. Dorsam, Y. Kong, K. M. West, C. F. Morrison, and A. J. Harmar Enhanced delayed-type hypersensitivity and diminished immediate-type hypersensitivity in mice lacking the inducible VPAC2 receptor for vasoactive intestinal peptide PNAS, October 31, 2001; (2001) 241503798. [Abstract] [Full Text] [PDF]

				A. METWALI, A. M. BLUM, J. LI, D. E. ELLIOTT, and J. V. WEINSTOCK IL-4 regulates VIP receptor subtype 2 mRNA (VPAC2) expression in T cells in murine schistosomiasis FASEB J, May 1, 2000; 14(7): 948 - 954. [Abstract] [Full Text]

				J.-C. Marie, A. Wakkach, A.-M. Coudray, E. Chastre, S. Berrih-Aknin, and C. Gespach Functional Expression of Receptors for Calcitonin Gene-Related Peptide, Calcitonin, and Vasoactive Intestinal Peptide in the Human Thymus and Thymomas from Myasthenia Gravis Patients J. Immunol., February 15, 1999; 162(4): 2103 - 2112. [Abstract] [Full Text] [PDF]

				N. JABRANE-FERRAT, D. BLOOM, A. WU, L. LI, D. LO, S. P. SREEDHARAN, C. W. TURCK, and A. E. J. GOETZL Enhancement by vasoactive intestinal peptide of {gamma}-interferon production by antigen-stimulated type 1 helper T cells FASEB J, February 1, 1999; 13(2): 347 - 353. [Abstract] [Full Text]

				M. Xia, S. P. Sreedharan, D. R. Bolin, G. O. Gaufo, and E. J. Goetzl Novel Cyclic Peptide Agonist of High Potency and Selectivity for the Type II Vasoactive Intestinal Peptide Receptor J. Pharmacol. Exp. Ther., May 1, 1997; 281(2): 629 - 633. [Abstract] [Full Text]

				M. D. Siegel, D.-H. Zhang, P. Ray, and A. Ray Activation of the Interleukin-5 Promoter by cAMP in Murine EL-4 Cells Requires the GATA-3 and CLE0 Elements J. Biol. Chem., October 13, 1995; 270(41): 24548 - 24555. [Abstract] [Full Text] [PDF]

				S. Paul, L. Li, R. Kalaga, P. Wilkins-Stevens, F. J. Stevens, and A. Solomon Natural Catalytic Antibodies: Peptide-hydrolyzing Activities of Bence Jones Proteins and V[IMAGE] Fragment J. Biol. Chem., June 23, 1995; 270(25): 15257 - 15261. [Abstract] [Full Text] [PDF]

				E. J. Goetzl, J. K. Voice, S. Shen, G. Dorsam, Y. Kong, K. M. West, C. F. Morrison, and A. J. Harmar Enhanced delayed-type hypersensitivity and diminished immediate-type hypersensitivity in mice lacking the inducible VPAC2 receptor for vasoactive intestinal peptide PNAS, November 20, 2001; 98(24): 13854 - 13859. [Abstract] [Full Text] [PDF]